Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -6.49%101.29M | 1.40%98.24M | 6.07%105.46M | 5.54%419.17M | 13.00%115.83M | 7.13%108.32M | 1.90%96.88M | 0.95%99.42M | 3.58%397.18M | -0.26%102.51M |
| Cost of revenue | -3.73%388.72M | 6.83%403.8M | ||||||||
| Gross profit | 560.33%30.45M | -220.38%-6.61M | ||||||||
| Operating expense | -3.57%102.86M | -1.00%97.77M | 2.39%103.29M | -15.70%23.54M | -3.98%108.4M | -3.19%106.66M | -5.57%98.76M | -3.06%100.88M | 36.26%27.92M | 141.27%112.89M |
| Other operating expenses | -3.95%104.85M | -2.12%99.7M | 1.63%105.65M | -4.09%35.51M | -4.32%110.72M | -2.45%109.16M | -4.53%101.86M | -2.39%103.95M | 16.88%37.02M | 142.84%115.72M |
| Total other operating income | -20.41%1.99M | -37.69%1.93M | -23.24%2.36M | 31.50%11.97M | -17.90%2.33M | 44.70%2.5M | 47.36%3.1M | 25.95%3.08M | -18.61%9.1M | -15.91%2.83M |
| Operating profit | -194.57%-1.57M | 125.07%471K | 249.31%2.17M | 120.02%6.91M | 171.61%7.44M | 118.27%1.66M | 80.25%-1.88M | 73.92%-1.45M | -130.30%-34.54M | -517.83%-10.38M |
| Net non-operating interest income (expenses) | -0.79%-1.16M | -1.36%-1.05M | -31.25%-1.37M | 3.69%-4.82M | -28.62%-1.5M | 7.66%-1.15M | 21.62%-1.03M | 18.43%-1.04M | -13.31%-5M | 29.52%-1.17M |
| Non-operating interest expense | 0.79%1.16M | 1.36%1.05M | 31.25%1.37M | -3.69%4.82M | 28.62%1.5M | -7.66%1.15M | -21.62%1.03M | -18.43%1.04M | 13.31%5M | -29.52%1.17M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 88.22%-39K | -59.82%133K | -96.08%12K | 13.70%164.07K | -162.84%-481K | -290.23%-331K | 224.51%331K | 500.00%306K | 346.61%144.3K | 89.92%-183K |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -1,641.90%-2.76M | 82.84%-443K | 137.39%818K | 105.74%2.26M | 146.48%5.45M | 101.77%179K | 75.95%-2.58M | 67.82%-2.19M | -103.29%-39.39M | -127.72%-11.73M |
| Income tax | 60.99%1.72M | 180.31%897K | 135.29%760K | 718.55%4.22M | 194.82%1.8M | 126.96%1.07M | -40.41%320K | 59.11%323K | 83.09%-682.02K | -139.84%-1.89M |
| Net income | -403.48%-4.48M | 53.81%-1.34M | 102.31%58K | 94.94%-1.96M | 137.18%3.66M | 91.60%-890K | 74.25%-2.9M | 64.14%-2.51M | -152.29%-38.71M | -125.52%-9.84M |
| Net income continuous operations | -403.48%-4.48M | 53.81%-1.34M | 102.31%58K | 94.94%-1.96M | 137.18%3.66M | 91.60%-890K | 74.25%-2.9M | 64.14%-2.51M | -152.29%-38.71M | -125.52%-9.84M |
| Noncontrolling interests | -248.61%-804K | -1,176.19%-226K | 163.61%222K | 97.38%-102.28K | 37.22%-1.1M | 122.14%541K | -73.08%21K | -268.60%-349K | -303.08%-3.91M | -296.48%-1.75M |
| Net income attributable to the company | -156.95%-3.68M | 61.88%-1.11M | 92.41%-164K | 94.67%-1.86M | 158.79%4.76M | 82.46%-1.43M | 74.24%-2.92M | 70.01%-2.16M | -101.54%-34.8M | -54.01%-8.09M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -156.95%-3.68M | 61.88%-1.11M | 92.41%-164K | 94.67%-1.86M | 158.79%4.76M | 82.46%-1.43M | 74.24%-2.92M | 70.01%-2.16M | -101.54%-34.8M | -54.01%-8.09M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -133.33%-0.0007 | 60.00%-0.0002 | 92.50%-0 | 95.24%-0.0003 | 160.00%0.0009 | 78.57%-0.0003 | 75.00%-0.0005 | 69.23%-0.0004 | -103.23%-0.0063 | -50.00%-0.0015 |
| Diluted earnings per share | -133.33%-0.0007 | 60.00%-0.0002 | 92.50%-0 | 95.24%-0.0003 | 150.00%0.0009 | 83.33%-0.0003 | 75.00%-0.0005 | 75.00%-0.0004 | -65.79%-0.0063 | -38.46%-0.0018 |
| Dividend per share | 0 | 100.00%0.002 | 0 | -33.33%0.001 | 0 | 0 | -33.33%0.001 | 0 | 0.0015 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.